A Study of GFH018 in Combination With Toripalimab in Patients With Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2023-11-10
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety/tolerability, pharmacokinetics, and
preliminary efficacy of GFH018 in combination with Toripalimab in patients with advanced
solid tumors.